This company has been marked as potentially delisted and may not be actively trading. Rain Oncology (RAIN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesInsider TradesTrendsBuy This Stock RAIN vs. NVAC, BUJA, OAKU, CSLM, PORT, AFAR, SWSS, JVSA, AFJK, and FTIIShould you be buying Rain Oncology stock or one of its competitors? The main competitors of Rain Oncology include NorthView Acquisition (NVAC), Bukit Jalil Global Acquisition 1 (BUJA), Oak Woods Acquisition (OAKU), CSLM Acquisition (CSLM), Southport Acquisition (PORT), Aura FAT Projects Acquisition (AFAR), Clean Energy Special Situations (SWSS), JVSPAC Acquisition (JVSA), Aimei Health Technology (AFJK), and FutureTech II Acquisition (FTII). These companies are all part of the "holding & other investment offices" industry. Rain Oncology vs. NorthView Acquisition Bukit Jalil Global Acquisition 1 Oak Woods Acquisition CSLM Acquisition Southport Acquisition Aura FAT Projects Acquisition Clean Energy Special Situations JVSPAC Acquisition Aimei Health Technology FutureTech II Acquisition NorthView Acquisition (NASDAQ:NVAC) and Rain Oncology (NASDAQ:RAIN) are both small-cap companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability, community ranking and analyst recommendations. Which has better earnings and valuation, NVAC or RAIN? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNorthView AcquisitionN/AN/AN/AN/AN/ARain OncologyN/AN/A$3.10MN/AN/A Is NVAC or RAIN more profitable? Company Net Margins Return on Equity Return on Assets NorthView AcquisitionN/A N/A N/A Rain Oncology N/A N/A -9.51% Does the MarketBeat Community believe in NVAC or RAIN? Rain Oncology received 26 more outperform votes than NorthView Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformNorthView AcquisitionN/AN/ARain OncologyOutperform Votes2652.00% Underperform Votes2448.00% Does the media favor NVAC or RAIN? In the previous week, Rain Oncology had 4 more articles in the media than NorthView Acquisition. MarketBeat recorded 4 mentions for Rain Oncology and 0 mentions for NorthView Acquisition. NorthView Acquisition's average media sentiment score of 0.00 beat Rain Oncology's score of -0.29 indicating that NorthView Acquisition is being referred to more favorably in the media. Company Overall Sentiment NorthView Acquisition Neutral Rain Oncology Neutral Do institutionals and insiders hold more shares of NVAC or RAIN? 9.8% of NorthView Acquisition shares are held by institutional investors. Comparatively, 25.8% of Rain Oncology shares are held by institutional investors. 80.7% of NorthView Acquisition shares are held by insiders. Comparatively, 17.4% of Rain Oncology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryNorthView Acquisition and Rain Oncology tied by winning 3 of the 6 factors compared between the two stocks. Get Rain Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for RAIN and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RAIN vs. The Competition Export to ExcelMetricRain OncologyHolding Offices IndustryBusiness SectorNASDAQ ExchangeMarket Cap$25.93M$473.79M$22.15B$7.93BDividend YieldN/A7.74%2.58%4.22%P/E RatioN/A2.4130.6818.54Price / SalesN/A54.24171.49103.30Price / Cash7.4169.0131.5134.62Price / Book-6.783.665.024.25Net Income$3.10M$35.22M$194.53M$248.18M Rain Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RAINRain OncologyN/A$4.68+5.9%N/AN/A$25.93MN/A0.0063News CoverageGap DownHigh Trading VolumeNVACNorthView AcquisitionN/A$12.10flatN/AN/A$71.78MN/A0.00N/ABUJABukit Jalil Global Acquisition 1N/A$14.47+1.7%N/A+36.5%$71.47MN/A0.00N/APositive NewsGap DownOAKUOak Woods AcquisitionN/A$11.70+0.1%N/A+9.1%$70.64MN/A0.00N/APositive NewsCSLMCSLM AcquisitionN/A$11.27-6.1%N/A+1.2%$68.92MN/A0.00N/AGap DownPORTSouthport AcquisitionN/A$11.72+2.2%N/AN/A$67.84MN/A0.002,021News CoverageHigh Trading VolumeAFARAura FAT Projects AcquisitionN/A$11.68flatN/AN/A$67.53MN/A0.002High Trading VolumeSWSSClean Energy Special SituationsN/A$10.70flatN/AN/A$67.31MN/A0.003High Trading VolumeJVSAJVSPAC AcquisitionN/A$10.77+0.1%N/A+6.6%$67.30MN/A0.00N/APositive NewsAFJKAimei Health TechnologyN/A$10.97-0.3%N/A+6.8%$67.16MN/A0.00N/ANews CoveragePositive NewsFTIIFutureTech II AcquisitionN/A$11.50flatN/AN/A$67.05MN/A0.002News Coverage Related Companies and Tools Related Companies NorthView Acquisition Competitors Bukit Jalil Global Acquisition 1 Competitors Oak Woods Acquisition Competitors CSLM Acquisition Competitors Southport Acquisition Competitors Aura FAT Projects Acquisition Competitors Clean Energy Special Situations Competitors JVSPAC Acquisition Competitors Aimei Health Technology Competitors FutureTech II Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RAIN) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rain Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rain Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RAIN Stock Free RAIN Stock Alerts